Imexpharm achieves VND2,205 billion in net revenue in 2024
According to its Jan. 20 announcement, the result was primarily driven by strong sales in the ETC channel (Ethical Drugs) and the performance of high-quality, high-value products produced at the company's EU-GMP facilities. EBITDA grew by…